Ibex: Studies to Be Presented at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Brigham and Women's Hospital and Champalimaud Foundation research shows high accuracy levels of Galen Breast in identifying...

ArteraAI: The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based...

Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by...

Deep Bio: An artificial intelligence-based prostate cancer diagnosis aid developed by a Korean company has received marketing authorization from overseas regulators, attracting the industry’s attention. Deep Bio said Tuesday that its...

Paige and Ohio State Wexner Medical Center: The Multi-Arm Study Will Utilize Paige Prostate Detect, the Only FDA Approved AI in Pathology for Detecting Prostate Cancer NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital...

Paige platform to be adopted by University of Florida College of Medicine - Jacksonville to improve cancer diagnoses NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical artificial...